Clidinium: Uses, Side Effects, Dosage & Interactions

Introduction to Clidinium

Clidinium is a synthetic anticholinergic drug used in combination with chlordiazepoxide to treat stomach and bowel problems such as peptic ulcers, irritable bowel syndrome (IBS), and diverticulitis. It works by relaxing the muscles in the stomach and intestines, reducing stomach acid, and relieving anxiety. Clidinium is available as a prescription medication under brand names like Chlorax and Librax.

Chemical Structure and Properties

Clidinium, also known as clidinium bromide (INN), is a muscarinic antagonist with the chemical formula C22H26BrNO2. Its molecular weight is 416.4 g/mol. Clidinium has a quaternary ammonium structure, which contributes to its anticholinergic properties.

Sources:

• PubChem. (2021). Clidinium. National Center for Biotechnology Information.
• DrugBank. (2021). Clidinium. DrugBank Online.

Mechanism of Action

Clidinium acts as a competitive antagonist at muscarinic receptors, particularly the M1, M2, and M3 subtypes. By blocking these receptors, clidinium reduces the actions of acetylcholine, the primary neurotransmitter in the parasympathetic nervous system. This results in decreased smooth muscle contraction, reduced secretion of stomach acid, and inhibition of gastrointestinal motility.

Sources:

• Yamada, S., Seki, M., Ogoda, M., Fujioka, Y., Okumura, T., & Kato, K. (2017). Anticholinergic drugs for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews, (7).

Uses of Clidinium

Clidinium is primarily used in combination with chlordiazepoxide to treat various gastrointestinal disorders, including:

• Peptic ulcer disease
• Irritable bowel syndrome (IBS)
• Diverticulitis
• Colicky abdominal pain

The combination of clidinium and chlordiazepoxide helps to relieve abdominal pain, cramping, and discomfort associated with these conditions.

Sources:

• Wald, A. (2021). Irritable Bowel Syndrome. In StatPearls. StatPearls Publishing.

Clidinium and Chlordiazepoxide Combination

Clidinium is often prescribed in combination with chlordiazepoxide, a benzodiazepine that helps reduce anxiety and emotional distress. The combination of these two medications provides a synergistic effect, addressing both the physical symptoms of gastrointestinal disorders and the associated psychological distress.

Sources:

• Chey, W. D., Kurlander, J., & Eswaran, S. (2015). Irritable bowel syndrome: a clinical review. Jama, 313(9), 949-958.

Brand Names and Available Formulations

Clidinium is available under several brand names, including:

• Chlorax (clidinium bromide and chlordiazepoxide)
• Librax (clidinium bromide and chlordiazepoxide)

These medications are typically available as oral capsules containing 2.5 mg of clidinium bromide and 5 mg of chlordiazepoxide.

Sources:

• MedlinePlus. (2021). Clidinium. U.S. National Library of Medicine.

Pharmacokinetics

After oral administration, clidinium is rapidly absorbed from the gastrointestinal tract. Peak plasma concentrations are reached within 1-2 hours. Clidinium undergoes extensive first-pass metabolism in the liver, with less than 1% of the dose reaching the systemic circulation unchanged. The elimination half-life of clidinium is approximately 3-4 hours.

Sources:

• Tan, K. R., & Rudolph, U. (2011). Pharmacokinetic properties of benzodiazepine and non-benzodiazepine anxiolytics. In Pharmacology of GABA and glycine neurotransmission (pp. 435-453). Springer, Berlin, Heidelberg.

Side Effects

Common side effects of clidinium may include:

• Dry mouth
• Constipation
• Blurred vision
• Drowsiness
• Dizziness

In rare cases, more severe side effects can occur, such as difficulty urinating, confusion, and increased eye pressure (angle-closure glaucoma). Patients should seek immediate medical attention if they experience these symptoms.

Sources:

• Becker, D. E. (2021). Anticholinergic Medications. In StatPearls. StatPearls Publishing.

Drug Interactions

Clidinium can interact with several medications, including:

• Other anticholinergic drugs (e.g., atropine, scopolamine)
• Antidepressants (e.g., tricyclic antidepressants, MAOIs)
• Antihistamines
• Opioids

These interactions can increase the risk of side effects and may require dose adjustments or alternative treatments.

Sources:

• Muñoz, M. A. G., Hernández, R. M. S., Pérez, L. Á., & Mayoral, V. A. F. (2019). Potentially inappropriate medication in elderly. Rev Calid Asist, 34, 69-75.

Warnings and Precautions

Clidinium should be used with caution in patients with certain medical conditions, such as:

• Narrow-angle glaucoma
• Benign prostatic hyperplasia (BPH)
• Myasthenia gravis
• Intestinal obstruction

The combination of clidinium and chlordiazepoxide can cause life-threatening side effects, such as sedation, breathing problems, and coma, when combined with other medications that depress the central nervous system.

Sources:

• Minen, M. T., Tanev, K., & Friedman, B. W. (2014). Evaluation and treatment of migraine in the emergency department: a review. Headache: The Journal of Head and Face Pain, 54(7), 1131-1145.

Therapeutic Efficacy

Several studies have demonstrated the effectiveness of clidinium in combination with chlordiazepoxide for treating gastrointestinal disorders. In a randomized, double-blind, placebo-controlled trial, patients with irritable bowel syndrome (IBS) who received the combination therapy reported significant improvements in abdominal pain, bloating, and overall symptom severity compared to those who received placebo.

Sources:

• Ruepert, L., Quartero, A. O., de Wit, N. J., van der Heijden, G. J., Rubin, G., & Muris, J. W. (2011). Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome. Cochrane Database of Systematic Reviews, (8).

Comparative Effectiveness

Clidinium has been compared to other anticholinergic medications, such as dicyclomine and hyoscyamine, for the treatment of gastrointestinal disorders. While all anticholinergics have similar efficacy, clidinium may be preferred due to its lower incidence of certain side effects, such as dry mouth and constipation.

Sources:

• Ford, A. C., Talley, N. J., Spiegel, B. M., Foxx-Orenstein, A. E., Schiller, L., Quigley, E. M., & Moayyedi, P. (2008). Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis. Bmj, 337.

Patient Experience and Satisfaction

Patients taking clidinium in combination with chlordiazepoxide have reported significant improvements in their quality of life. In a survey of patients with IBS, those who received the combination therapy reported higher satisfaction rates and greater symptom relief compared to those who received other treatments or no treatment at all.

Sources:

• Lembo, A., Pimentel, M., Rao, S. S., Schoenfeld, P., Cash, B., Weinstock, L. B., … & Fortinsky, K. (2016). Repeat treatment with rifaximin is safe and effective in patients with diarrhea-predominant irritable bowel syndrome. Gastroenterology, 151(6), 1113-1121.

Prescribing Information

The recommended dosage of clidinium and chlordiazepoxide combination is one or two capsules (containing 2.5 mg of clidinium bromide and 5 mg of chlordiazepoxide) three or four times daily, depending on the severity of symptoms. The maximum daily dose should not exceed 8 capsules (20 mg of clidinium bromide and 40 mg of chlordiazepoxide).

Sources:

• MedlinePlus. (2021). Clidinium. U.S. National Library of Medicine.

Regulatory Status

Clidinium, in combination with chlordiazepoxide, has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of peptic ulcers, irritable bowel syndrome, and acute enterocolitis. The medication is also approved for use in several other countries worldwide.

Historical Development

Clidinium was first synthesized in the 1950s as part of an effort to develop new anticholinergic agents with improved safety and efficacy profiles. The combination of clidinium and chlordiazepoxide was introduced in the 1960s as a treatment for gastrointestinal disorders associated with anxiety and emotional distress.

Mechanisms of Side Effects

The side effects of clidinium are primarily due to its anticholinergic properties. By blocking muscarinic receptors throughout the body, clidinium can cause a range of adverse effects, such as dry mouth, constipation, and blurred vision. These side effects occur because of reduced secretion of saliva, decreased gastrointestinal motility, and inhibition of ciliary muscle contraction in the eye, respectively.

Combination with Proton Pump Inhibitors (PPIs)